News

Biomedical researchers at KU Leuven have found a new way to study endometrial diseases such as endometriosis and cancer. They were able to grow three-dimensional cell structures from diseased tissue of patients. The biobank can be used to unravel the disorders and test drugs.

Scientists have devised a new computational method that reveals genetic patterns in the massive jumble of individual cells in the body.

Scientists using an experimental treatment have slowed the progression of scrapie, a degenerative central nervous disease caused by prions, in laboratory mice and greatly extended the rodents’ lives, according to a new report.

A rare, short-lived population of immune cells in the bloodstream may serve as "periscopes" to monitor immune status via lymph nodes deep inside the body.

Use of the illegal stimulant methamphetamine causes build-up of tough protein fibers in the heart muscle, which may help explain the development of enlarged hearts and heart failure users of the drug.

Carnegie Mellon University researchers have published in Science a new 3D bioprinting method that brings the field of tissue engineering one step closer to being able to 3D print a full-sized, adult human heart.

A proteomics-based protein-protein interaction study has led to the discovery of proteins that interact with a legume receptor that mediates signal transduction from the plasma membrane to the nucleus. This shows how symbiotic signals from symbiotic bacteria are transmitted upon perception, ultimately leading to their accommodation within the host plant.

A detailed genetic study, reveals some surprising – and even mysterious – findings about how a contagious canine cancer, that has survived for thousands of years, and mutated and evolved over time.

Though food allergy affects more than 4.8 million children in the United States, no approved preventative treatments currently exist. A new study to evaluate an experimental treatment for food allergy could alleviate this risk.

A novel experimental vaccine against respiratory syncytial virus (RSV), a leading cause of severe respiratory illness in the very young and the old, has shown early promise in a Phase 1 clinical trial.